TerminatedNot Applicable

Efficacy of a Foot Strengthening Protocol on Sport Performance Kinetics

Stopped: inclusion rate too low

France30 participantsStarted 2023-02-03

Plain-language summary

This randomized controlled trial aims to explore the effect of a foot strengthening protocol on toe flexion strength, foot deformation and morphology as well as kinetics during sprinting, cutting and jumping in healthy athletes (18-40 completed years). The study consists of a 4 weeks control period, followed by 8 weeks intervention period and 4 weeks follow up

Who can participate

Age range

18 Years – 40 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria : * To be affiliated in the federation of one of the following sports : soccer, handball, rugby, basketball or track and field; * To practice their respective sport more than two times per week; * Be affiliated or beneficiary of a social security insurance; * Having freely given their written consent after having been informed of the purpose, the procedure and the potential risks involved. * Licensed in a tennis club (FFT) and in a volleyball club (FFVolley) Exclusion criteria : * Use of pharmacological therapy to match gander identity; * Have an abnormal range of motion of the toes and/or ankle; * Have any kind of ankle or foot pain (self-defined and self-reported by the FAAM questionnaire) in the previous 6 months; * Have a previous injury or surgery of the lower limb in the previous 6 months; * Have a neurological or vestibular deficit that may affect walking or balance (lumbar-sacral radiculopathy, peripheral nerve pathology, Marfan or Eehlers-Danlos syndrome, etc.); * Have contraindication to neuromuscular electrical stimulation (pacemaker, seizure disorders, pregnancy); * Have a previous foot strengthening experience in the past 6 months for at least 2 weeks and more than one session per week; * Participate at the same time in another medical interventional experiment or have participated in such a study in the 30 days preceding this study; * Being unable to understand the purpose and conditions of the study, and to give consent; * Being deprived o…

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

maximal isometric joint flexion muscle strength MTP (in N)

Timeframe: Change from baseline to Week 18

Trial details

NCT IDNCT05574322

SponsorCentre Hospitalier Universitaire de Saint Etienne

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-02-14

View on ClinicalTrials.gov More Healthy Athletes trials